Bioinformatics FAQ (Frequently Asked Questions) - What is bioinformatics
Part:
1
2
3
4
5
6
(Continued from previous part...)
What is Pharmacogenomics?
Pharmacogenomics is the application of genomic approaches and
technologies to the identification of drug targets. Examples include
trawling entire genomes for potential receptors by bioinformatics
means, or by investigating patterns of gene expression in both
pathogens and hosts during infection, or by examining the
characteristic expression patterns found in tumours or patients
samples for diagnostic purposes (possibly in the pursuit of
potential cancer therapy targets).
The term "pharmacogenomics" is used for the more "trivial"---but
arguably more useful---application of bioinformatics approaches to
the cataloguing and processing of information relating to
pharmacology and genetics, for example the accumulation of
information in databases like this one.
(Thanks to Ivanovi.)
What is Pharmacogenetics?
All individuals respond differently to drug treatments; some
positively, others with little obvious change in their conditions
and yet others with side effects or allergic reactions. Much of this
variation is known to have a genetic basis. Pharmacogenetics is a
subset of pharmacogenomics which uses genomic/bioinformatic methods
to identify genomic correlates, for example SNPs (Single
Nucleotide Polymorphisms), characteristic of
particular patient response profiles and use those markers to inform
the administration and development of therapies. Strikingly, such
approaches have been used to "resurrect" drugs thought previously to
be ineffective, but subsequently found to work with in subset of
patients. They can also be used for optimizing the doses of
chemotherapy for particular patients.
Overview of most common bioinformatics programs
Everyday bioinformatics is done with sequence search programs
like BLAST,
sequence analysis programs, like the EMBOSS and Staden packages,
structure prediction programs like THREADER
or PHD
or molecular imaging/modelling programs like RasMol and WHATIF.
Overview of most common bioinformatics technology
Currently, a lot of bioinformatics work is concerned with the
technology of databases
(Thanks again to Ivanovi.) These databases include both "public"
repositories of gene data like GenBank
or the Protein DataBank (the
PDB), and private databases, like those used by research groups
involved in gene mapping projects or those held by biotech
companies. Making such databases accessible via open standards is
very important. Consumers of bioinformatics data use a range of
computer platforms: from the more powerful and forbidding UNIX boxes
favoured by the developers and curators to the far friendlier Macs
often found populating the labs of computer-wary biologists.
Databases of existing sequencing data can be used to identify
homologues of new molecules that have been amplified and
sequenced in the lab. The property of sharing a common ancestor,
homology, can be a very powerful indicator in
bioinformatics (see below).
Acquisition of sequence data
Bioinformatics tools can be used to obtain sequences of genes or
proteins of interest, either from material obtained, labelled,
prepared and examined in electric fields by individual
researchers/groups or from repositories of sequences from previously
investigated material.
Analysis of data
Both types of sequence can then be analysed in many ways with
bioinformatics tools.
They can be assembled. Note that this is one of the
occasions when the meaning of a biological term differs markedly
from a computational one (see the amusing confusion
over the issue at Web-based geek forum Slashdot). Computer scientists,
banish from your mind any thought of assembly language. Sequencing
can only be performed for relatively short stretches of a
biomolecule and finished sequences are therefore prepared by
arranging overlapping "reads" of monomers (single beads on
a molecular chain) into a single continuous passage of "code".
This is the bioinformatic sense of assembly.
(Continued on next part...)
Part:
1
2
3
4
5
6
|